摘要 |
The present invention relates to the CGIc compound for inhibiting the expression and activation of MMP-9 in HTl 080 and the MMP-9 inhibitor comprising the CGIc compound as an effective ingredient, which can inhibits the expression of AP-I in HtI 080 to effectively inhibit the expression and activation of MMP-9 such that it is effectuated in treating a wound, metastasis, rheumatoid arthritis, inflammation, hyperparathyroidism, diabetes, cornel ulcer, osteoporosis, stomach ulcer, trauma, pimple, burn, periodontal disease, arteriosclerosis or fracture. |
申请人 |
PUKYONG NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION;KIM, MOON MOO;KIM, SE KWON;MENDIS, ERESHA |
发明人 |
KIM, MOON MOO;KIM, SE KWON;MENDIS, ERESHA |